Skip to main content
Log in

Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls

  • Brief Report
  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

Background

Tc-99m pyrophosphate (PYP) SPECT is recommended for indeterminate findings on planar imaging. We aimed to compare the findings on planar PYP scintigraphy alone to that of routinely performed PYP SPECT.

Methods

PYP scintigraphy data of 133 patients (53% men; mean age 76 years) were evaluated. SPECT was routinely performed following 1-hour planar imaging, in all cases. Semiquantitative visual score and heart-to-contralateral (H/CL) ratio were determined in all patients as recommended.

Results

PYP images from 35 patients (26%) were considered to be positive based on SPECT myocardial uptake. Among them, 20 (57%) had a H/CL ratio ≥1.5 and 34 had a visual score ≥ 2. SPECT identified myocardial uptake in one patient with a visual score < 2 and refuted the presence of myocardial uptake in two patients with a visual score ≥ 2. Visual score correlated well with SPECT (r = 0.94; P < .0001) and had an accuracy of 98% for tomographic myocardial uptake. Addition of H/CL ratio reduced the diagnostic performance of visual score.

Conclusions

Planar-derived visual score has an excellent accuracy for tomographic myocardial uptake, though it misclassifies a small proportion of patients. H/CL ratio decreases the diagnostic certainty of planar imaging. Tomographic imaging prevents misdiagnoses and should always be performed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4

Abbreviations

PYP:

Techneticum-99m pyrophosphate

TTR-CA:

Transthyretin cardiac amyloidosis

H/CL:

Heart-to-contralateral

ASNC:

American Society of Nuclear Cardiology

SPECT:

Single photon emission computed tomography

LVEF:

Left ventricular ejection fraction

References

  1. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133:2404–12.

    Article  CAS  Google Scholar 

  2. Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol. 2005;46:1076–84.

    Article  Google Scholar 

  3. Bokhari S, Castaño A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging. 2013;6:195–201.

    Article  Google Scholar 

  4. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Card Fail. 2019;25:e1–39.

    Article  Google Scholar 

  5. Masri A, Bukhari S, Ahmad S, Nieves R, Eisele YS, Follansbee W, et al. Efficient 1-hour technetium-99 m pyrophosphate imaging protocol for the diagnosis of transthyretin cardiac amyloidosis. Circ Cardiovasc Imaging. 2020;13:e010249.

    Article  Google Scholar 

  6. Sperry BW, Burgett E, Bybee KA, McGhie AI, O’Keefe JH, Saeed IM et al. Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: Imaging at 1 vs 3 hours and planar vs SPECT/CT. J Nucl Cardiol 2020.

  7. Asif T, Araujo T, Singh V, Malhotra S. High prevalence of heart failure with reduced ejection fraction in patients with transthyretin cardiac amyloidosis. J Nucl Cardiol. 2020;27:1044–6.

    Article  Google Scholar 

  8. Gertz MA, Brown ML, Hauser MF, Kyle RA. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis. Arch Intern Med. 1987;147:1039–44.

    Article  CAS  Google Scholar 

  9. Wehbe RM, Kansal P, Holly TA. Cases from a busy nuclear cardiology laboratory: Potential pitfalls in the interpretation of cardiac scintigraphy for ATTR cardiac amyloidosis. J Nucl Cardiol. 2020. https://doi.org/10.1007/s12350-020-02094-4.

    Article  PubMed  Google Scholar 

  10. Dorbala S, Bokhari S, Miller EJ, Bullock-Palmer R, Soman P, Thompson R. 99mTechnetium-pyrophosphate imaging for transthyretin cardiac amyloidosis. American Society of Nuclear Cardiology Practice Points 2016.

  11. Ramsay SC, Cuscaden C. The current status of quantitative SPECT/CT in the assessment of transthyretin cardiac amyloidosis. J Nucl Cardiol. 2019. https://doi.org/10.1007/s12350-019-01935-1.

    Article  PubMed  Google Scholar 

  12. Hussain M, Collier P, Jaber W. Value of SPECT imaging in patients with TTR-amyloid: Ratios are not enough. J Nucl Cardiol. 2019. https://doi.org/10.1007/s12350-019-01997-1.

    Article  PubMed  Google Scholar 

Download references

Disclosures

Talal Asif, Javier Gomez-Valencia, Vasvi Singh, Rami Doukky, and Arlet Nedeltcheva have nothing to disclose. Saurabh Malhotra—Speakers Bureau: Pfizer and Akcea Therapeutics, and Advisory Board: Akcea Therapeutics

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Saurabh Malhotra MD, MPH, FASNC.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The authors of this article have provided a PowerPoint file, available for download at SpringerLink, which summarizes the contents of the paper and is free for re-use at meetings and presentations. Search for the article DOI on SpringerLink.com.

Funding

This study was supported in part by the Becker Fund for Heart Research, Community Foundation of Greater Buffalo.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PPTX 894 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Asif, T., Gomez, J., Singh, V. et al. Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls. J. Nucl. Cardiol. 28, 104–111 (2021). https://doi.org/10.1007/s12350-020-02328-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-020-02328-5

Keywords

Navigation